PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors
Phase 1 Terminated
21 enrolled
Durvalumab and Grid Therapy for Non-small Cell Lung Cancer in Progression During or After Treatment With PACIFIC Regimen
Phase 1 Terminated
4 enrolled
Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC
Phase 1 Terminated
16 enrolled 9 charts
A Study of PHN-010 in Patients With Advanced Solid Tumors
Phase 1 Terminated
26 enrolled
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Phase 1 Terminated
79 enrolled 24 charts
Functional Lung Avoidance Radiation Therapy Using Hyperpolarized Xenon-129 MRI
Phase 1 Terminated
9 enrolled
Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors
Phase 1 Terminated
44 enrolled
A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
Phase 1 Terminated
4 enrolled
A Study to Investigate LYL797 in Adults With Solid Tumors
Phase 1 Terminated
57 enrolled
A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma
Phase 1 Terminated
241 enrolled
(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC
Phase 1 Terminated
177 enrolled
(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations
Phase 1 Terminated
103 enrolled
Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14)
Phase 1 Terminated
7 enrolled
Safety and Effectiveness of ABM-168 in Adults with Advanced Solid Tumors.
Phase 1 Terminated
12 enrolled
PDL1x41BB
Phase 1 Terminated
160 enrolled
Sirolimus and Durvalumab for the Treatment of Stage I-IIIA Non-small Cell Lung Cancer
Phase 1 Terminated
3 enrolled 7 charts
Hepatic Impairment Study for Lorlatinib in Cancer Patients
Phase 1 Terminated
1 enrolled 3 charts
Capmatinib Plus Trametinib for the Treatment of Metastatic Non-small Cell Lung Cancer With MET Exon 14 Skipping Mutation
Phase 1 Terminated
3 enrolled
Non-invasive Measurement of PD-L1 Levels With Positron Emission Tomography (PET) in Head and Neck Malignancies and Intracranial Metastases
Phase 1 Terminated
7 enrolled
LCL161 Plus Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies
Phase 1 Terminated
34 enrolled
FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors
Phase 1 Terminated
16 enrolled
(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC
Phase 1 Terminated
20 enrolled
A Study of TPX-0131, a Novel Oral ALK Tyrosine Kinase Inhibitor, in Patients With ALK+ Advanced or Metastatic NSCLC
Phase 1 Terminated
11 enrolled
CheckMate 76U
Phase 1 Terminated
21 enrolled
Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung Cancer
Phase 1 Terminated
3 enrolled
Five Fraction SABR Dose Escalation for Early Stage Squamous Cell Carcinoma of the Lung
Phase 1 Terminated
13 enrolled
Feasibility and Safety Study of Nivolumab With Irinotecan for Small Cell Lung Cancer
Phase 1 Terminated
10 enrolled
Study of CLR457 Administered Orally in Adult Patients With Advanced Solid Malignancies
Phase 1 Terminated
31 enrolled
MIMIG
Phase 1 Terminated
7 enrolled
Comfort Level of Two Abdominal Compression Methods Used to Hold Patients Still While Undergoing Stereotactic Body Radiation Therapy for Lung Tumors
Phase 1 Terminated
10 enrolled
D-1MT
Phase 1 Terminated
17 enrolled
PF-06671008 Dose Escalation Study in Advanced Solid Tumors
Phase 1 Terminated
28 enrolled 25 charts
Flaxseed Supplement in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Undergoing Chemotherapy and Radiation Therapy
Phase 1 Terminated
48 enrolled
Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas
Phase 1 Terminated
10 enrolled
Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or Mediastinum
Phase 1 Terminated
19 enrolled
Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer
Phase 1 Terminated
39 enrolled
Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas
Phase 1 Terminated
44 enrolled
Crizotinib Plus Pembrolizumab In Alk-Positive Advanced Non Small Cell Lung Cancer Patients
Phase 1 Terminated
9 enrolled 20 charts
Immunization of Patients With Non Small Cell Lung Cancer (NSCLC)
Phase 1 Terminated
1 enrolled
A Study Of PF-06263507 In Patients With Advanced Solid Tumors
Phase 1 Terminated
26 enrolled 26 charts
Sorafenib and Thoracic Radiation for Patients With Non-Small Cell Lung Cancer
Phase 1 Terminated
10 enrolled
Radiation Therapy (XRT) and ZD6474 in Non-Small Cell Lung Cancer (NSCLC)
Phase 1 Terminated
3 enrolled
VTNSCLC
Phase 1 Terminated
1 enrolled
Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid Tumors
Phase 1 Terminated
5 enrolled
Study of Pazopanib and Ixabepilone in Patients With Solid Tumors
Phase 1 Terminated
31 enrolled 12 charts
Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLC
Phase 1 Terminated
4 enrolled
Bronchial Artery Infusion of Gemcitabine in Treating Patients With Recurrent or Progressive Non-Small Cell Lung Cancer
Phase 1 Terminated
4 enrolled
IR-guided Ablation (IRGA) Combined With Stereotactic Ablative Radiation (SABR) for Large Lung Tumors
Phase 1 Terminated
1 enrolled
Proton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung Cancer
Phase 1 Terminated
4 enrolled
Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLC
Phase 1 Terminated
10 enrolled